Telemedicine is revolutionizing the cannabis industry and as a result, companies like NamasteMD can provide patients more accessibility to medical cannabis than ever before. (123rf)

Emblem Corp. (TSXV: EMC) (TSXV: EMC.WT) ("Emblem" or the "Company") and Canntab Therapeutics Limited (CSE: PILL) ("Canntab") are pleased announce to receipt of Health Canada approval for research and development activities on oral sustained release formulations of cannabinoids (the "Sustained Release Product" or the "Product"), which are the proprietary products conceived by Canntab representing significant progress in Emblem and Canntab's partnership to develop long-acting cannabis formulations.

CBD oil is a controlled substance — and the 'jury is still out' on its health benefits.

Cannabidiol oil, or CBD, is generating a lot of buzz in the world of alternative medicine and many Canadians are buying in.

The oil, which is extracted from marijuana plants, doesn't have the same mind-altering effects as smoking pot. People rub it on their achy joints or put it under their tongue to help them sleep. Some purveyors say it's completely legal in Canada and can be used for a long list of ailments, including epilepsy and multiple sclerosis.

But federal authorities say CBD oil, which is widely available at head shops and online, is indeed illegal without a medical marijuana prescription. And its purported health benefits are also still in question.

A local clinic is embracing a more personal, science-based approach when it comes to prescribing medical cannabis for qualified patients.

After its initial launch in January, the Clinic Network of Canada (CNC) hosted the official grand opening of a new medical cannabis resource centre and pain management clinic at Pure Clinics in Sherwood Park on April 12.

Mike Lukacs, a cannabis educator and client services representative with CNC, said the clinic’s approach represents a necessary shift from traditional models in existence today.

“If people look at cannabis from a medical standpoint, and they have a treatable condition, they don’t just want a prescription and then to be left to figure it out themselves,” he noted.

Baby boomers expected to drive sales as they switch to cannabis from other medications.

Cannabis-sector CEOs are bullish about the prospect for sales once Canada legalizes marijuana and say that the market will soar far above many estimates.

At the Arcview Group’s cannabis investment conference on May 2, the CEOs of three Canadian cannabis companies were united in predicting the legal cannabis market in Canada will fast outpace expectations.

A recent New Frontier Data report pinned the domestic cannabis market in Canada at $9.2 billion by 2025, sustained by higher average medical consumption. More conservative estimates pin federal sales at $4.5 billion by 2027.

Following the company’s third quarter results, PI Financial analyst Jason Zandberg is feeling bullish about Aurora Cannabis (TSX:ACB).

On May 8, ACB posted its Q3, 2018 results. The company lost $20.79-million on revenue of $16.1-million, a topline that was up 211 per cent over last year’s third quarter.

Consumers in recreational industry must do own research into medical cannabis remedies.

Albertans hoping to learn whether or not cannabis could help their aches and pains won't get any answers from employees at recreational retail cannabis stores.

Once cannabis is legalized, pot shop employees will not be allowed to give medical advice or guidance to consumers. If consumers ask which strain of cannabis might be best to manage arthritis pain, for example, employees must refer them to their doctors or other health-care practitioners.

The guidelines are part of the Alberta Gaming, Liquor and Cannabis Commission's SellSafe cannabis staff training, a mandatory program for anyone who plans to work in the recreational cannabis industry.

MONCTON – Medical marijuana producer Organigram Holdings is making it first foray into the international cannabis market, buying a 25 per cent stake in the German company Alpha-Cannabis Germany (ACG).

The company will spend approximately $2.5-million in cash and $1.3-million in shares for the stake. Once the deal is finalized, Organigram will provide Alpha-Cannabis with dried cannabis flower and sweet leaf to be converted into extracts meant to supply the German medical cannabis market.

With the impending legalization of marijuana and a rise in the number of people using medical marijuana to treat any number of ailments, employers are increasingly concerned about how they will be able to manage or control marijuana use at work. The recent decision of the Ontario Human Rights Tribunal in Aitchison v. L & L Painting and Decorating Ltd. demonstrates that employees do not have unfettered rights when it comes to using medical marijuana in the workplace.

Concerns about access voiced Saturday at 12th Global Marijuana Rally in Halifax.

A rally and march held in Halifax Saturday highlighted lingering questions for medical cannabis users once marijuana is legalized in Canada July 1, 2018.

Dozens of people attended the 12th Global Marijuana Rally and March at Victoria Park. It was organized by the Maritimers Unite for Medical Marijuana Society, a registered not-for-profit organization that advocates for patients who use cannabis for medication.